University of Salamanca / Universidad de Salamanca

Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations (2021) Rosinol L, Beksac M, Zamagni E, Van De Donk NWCJ, Anderson KC, Badros A, Caers J, et al. Journal article, Review article Polymorphisms within the TNFSF4 and mapkapk2 loci influence the risk of developing invasive aspergillosis: A two-stage case control study in the context of the aspbiomics consortium (2021) Sanchez-Maldonado JM, Moniz-Diez A, Ter Horst R, Campa D, Cabrera-Serrano AJ, Martinez-Bueno M, Garrido-Collado MDP, et al. Journal article Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set (2020) Chari A, Samur MK, Martinez-Lopez J, Cook G, Biran N, Yong K, Hungria V, et al. Journal article Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study (2020) Dimopoulos MA, Lonial S, White D, Moreau P, Weisel K, San-Miguel J, Shpilberg O, et al. Journal article Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN) (2020) Terpos E, Engelhardt M, Cook G, Gay F, Mateos MV, Ntanasis-Stathopoulos I, Van De Donk NWCJ, et al. Journal article, Review article Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium (2020) Sanchez-Maldonado JM, Campa D, Springer J, Badiola J, Niazi Y, Moniz-Diez A, Hernandez-Mohedo F, et al. Journal article CONTRIBUTION OF DEFECTIVE NON-APOPTOTIC FAS SIGNALING TO IMMUNE DYSREGULATION IN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS) (2020) Staniek J, Kalina T, Andrieux G, Boerries M, Janowska I, Fuentes M, Bakardjieva M, et al. Conference contribution Polymorphisms within the ARNT2 and CX3CR1 genes are associated with the risk of developing invasive aspergillosis (2020) Lupianez CB, Martinez-Bueno M, Sanchez-Maldonado JM, Badiola J, Cunha C, Springer J, Lackner M, et al. Journal article Management of adults and children undergoing chimeric antigen receptor T-cell therapy: Best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) (2020) Yakoub-Agha I, Chabannon C, Bader P, Basak GW, Bonig H, Ciceri F, Corbacioglu S, et al. Journal article, Review article Chimeric antigen receptor T-cell therapy for multiple myeloma: A consensus statement from the European Myeloma Network (2019) Moreau P, Sonneveld P, Boccadoro M, Cook G, Victoria Mateos M, Nahi H, Goldschmidt H, et al. Journal article